# FSE2 Wave 1 resume gate report

Date: 2026-08-09

Starting branch HEAD: `b0a0e0d6723a676bd14ccf94d682c147726c0de7`

Required baseline and merge-base: `705e9d4bd203ca7b902ad0aeedc9d4402f9f4452`

Official frozen source: `ministero-salute/it-fse-support`
`430e6b5d9dde8a35b04ae635c11303db787a977e`

## Result

The freeze is current and the generic Wave 1 JWT/X.509 foundation is present. Connector
implementation is **BLOCKED_BY_TRUSTED_ACTOR_SOURCE** before provider or network use.
The product does not currently have an authoritative runtime source for the FSE healthcare
professional CF or organization identifier required as the dynamic JWT subject.

This report is PUBLIC_SAFE. It uses official public material and repository-local product
contracts only. No private/customer research, Sistema TS code, Regional FSE Consumer,
official FSE environment, production credential or clinical payload was accessed.

## Git and PR starting state

- worktree: `C:\Codice\broker-gateway-fse2`;
- branch: `wave1/fse2-national`;
- worktree clean at starting HEAD;
- merge-base with `origin/main`: exact required baseline `705e9d4...`;
- PR #16: open, base `main`, head `wave1/fse2-national`;
- no new PR and no merge performed.

## Official freeze currency

The lightweight public check resolved official repository `HEAD` and `refs/heads/main`
to the frozen commit `430e6b5...`. The comparison is `identical`, with zero later commits
and no changed files. No authentication or payload contract update exists after the
freeze. Result: **FROZEN_SPEC_ACCEPTED**.

## Availability and retry matrix

| Operation | Availability | Retry |
|---|---|---|
| CDA validation | `PRODUCTION_AVAILABLE` | `NO_AUTOMATIC_RETRY` |
| FHIR validation | `TEST_ONLY_OFFICIAL` | `NO_AUTOMATIC_RETRY` |
| Create | `PRODUCTION_AVAILABLE` | `NO_AUTOMATIC_RETRY` |
| Replace | `PRODUCTION_AVAILABLE` | `NO_AUTOMATIC_RETRY` |
| Delete | `PRODUCTION_AVAILABLE` | `NO_AUTOMATIC_RETRY` |
| Metadata update | `PRODUCTION_AVAILABLE` | `NO_AUTOMATIC_RETRY` |
| Chain concealment | `TEST_ONLY_OFFICIAL` | `NO_AUTOMATIC_RETRY` |
| Validate and create | `PRODUCTION_AVAILABLE` | `NO_AUTOMATIC_RETRY` |
| Validate and replace | `PRODUCTION_AVAILABLE` | `NO_AUTOMATIC_RETRY` |
| Workflow status | `PRODUCTION_AVAILABLE` | `SAFE_RETRY` |
| Trace status | `PRODUCTION_AVAILABLE` | `SAFE_RETRY` |
| Direct FHIR create/replace and inbound callback surfaces | `NOT_AVAILABLE` | N/A |

The matrix remains the approved frozen inventory. A test-only operation is not presented
as production-supported.

## Composition audit

The resumed Core can compose RS256, verified X.509 leaf/chain material, typed protected
`x5c`, `iat+exp` without `nbf`, typed trusted runtime subject binding, separate purpose-bound
mTLS, resource revision/disable checks, restricted transport and provider-exception
sanitization. Dual JWT, FSE issuer prefixes, CX/XON/IHE formatting, exact document hashing,
workflow semantics and official error mapping remain Healthcare responsibilities.

No new generic primitive is required or proposed. The official absence of a universal
lifetime/skew value is handled by requiring an existing validated, explicit server-owned
production policy; no FSE2 magic constant and no caller lifetime input is introduced.

## Blocking evidence

`GatewayClientPrincipal` contains server-derived Tenant, Application, Installation,
credential and protocol-scope identity only. Those values cannot establish a healthcare
professional CF or organization identifier. The production source contains no registered
implementation of `ITrustedRuntimeClaimValueResolver`; only generic synthetic unit-test
resolvers exist.

Consequently the following items are intentionally not implemented or claimed:

- FSE2 operation handlers and dual-JWT orchestration;
- issuer/CN, CX/XON/IHE and document-hash production paths;
- workflow persistence and RFC 7807 mapping;
- public Published Connector configuration;
- synthetic HTTPS/mTLS FSE2 server and negative matrix;
- rotate/disable, signing/X.509 and ordinary-suite results attributable to an FSE2 product;
- official accreditation or production readiness.

Provider invocation count: **0**. Network count: **0**. The stop happens from repository
authority inspection before any provider or outbound transport use.

## Required deployment integration

An authorized future change must provide a server-side actor authority that derives and
validates the official professional CF or organization identity from authenticated runtime
state. It must bind that material to the exact invocation and Published policy, provide
opaque authorization evidence, deny caller-originated/mismatched/stale values and register
the generic trusted runtime resolver. Positive and negative security tests and threat-model
traceability are required before this connector may be implemented.

Synthetic identities can qualify orchestration after that boundary exists, but cannot
replace the missing production authority. Official provisioning, signing and mTLS
certificates, conformance/accreditation, approved lifetime policy and live operational
evidence remain separate accreditation blockers.

Final status: **FSE2_IMPLEMENTATION = BLOCKED_BY_TRUSTED_ACTOR_SOURCE**.

## Local resume verification

- documentation validation: PASS;
- conservative secret scan: PASS;
- `git diff --check`: PASS;
- FSE2 product/unit/integration tests: 0, intentionally not created after the mandatory
  trusted-actor stop;
- official FSE, Hyper-V and accreditation tests: not run;
- build, ordinary, PostgreSQL, SBOM, vulnerability, Gitleaks and Core-export results for
  the pushed exact HEAD: delegated to the unchanged repository CI gate and reported only
  if that exact-head workflow completes successfully.
